Lispro is an insulin analogue produced by recombinant DNA technology. Which of the following statements about this form of insulin is NOT true?
A) Optimal time of preprandial injection is 15 minutes.
B) Duration of action is increased when the dose is increased.
C) It is compatible with NPH insulin.
D) It has no pronounced peak.
Correct Answer:
Verified
Q8: Administration of exenatide is by subcutaneous injection:
A)Thirty
Q9: GLP-1 agonists:
A)Directly bind to a receptor in
Q10: Hypoglycemia can result from the action of
Q11: Which characteristic of metformin makes it a
Q12: The decision may be made to switch
Q13: The action of gliptins is different from
Q14: All of the following are options for
Q15: Sitagliptin has been approved for:
A)Monotherapy in once-daily
Q16: Angiotensin-converting enzyme (ACE) inhibitors are considered renal-protective
Q17: Avoid concurrent administration of exenatide with which
Unlock this Answer For Free Now!
View this answer and more for free by performing one of the following actions
Scan the QR code to install the App and get 2 free unlocks
Unlock quizzes for free by uploading documents